Literature DB >> 9227327

Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression.

J A Quayle1, F Watson, R C Bucknall, S W Edwards.   

Abstract

Neutrophils isolated from the synovial fluid of 16/24 patients with rheumatoid arthritis expressed Fc gamma RI (CD64), the high-affinity receptor for monomeric immunoglobulin G (IgG), on their cell surface. Receptor expression ranged from 17% to 168% of the level of expression obtained after incubation of control blood neutrophils with 100 U/ml interferon-gamma (IFN-gamma) for 24 hr in vitro. Similarly, mRNA for Fc gamma RI was detected in synovial fluid neutrophils from 12/15 patients and transcript levels ranged from 5% to 200% of the values obtained after treatment of blood neutrophils with IFN-gamma for 4 hr in vitro. No surface expression nor mRNA were detected in freshly isolated blood neutrophils from either patients or from healthy controls. Addition of cell-free synovial fluid to control blood neutrophils induced both mRNA and surface expression of Fc gamma RI to levels that were comparable to those achieved after addition of IFN-gamma. Neither soluble nor insoluble immune complexes appeared to be involved in induction of Fc gamma RI expression in spite of the ability of these complexes to induce protein biosynthesis. Synovial fluid-induced expression of Fc gamma RI was partially blocked by incubation with neutralizing IFN-gamma antibodies, whilst neutralizing interleukin (IL)-6 antibodies had little effect. Levels of IFN-gamma measured within these synovial fluids ranged from 0 to 2.7 U/ml, well within the range known to induce neutrophil Fc gamma RI expression. These data thus indicate that gene expression in synovial fluid neutrophils is selectively activated as the cells enter the diseased joint. Furthermore, these data indicate that induced expression of Fc gamma RI may alter the ability of infiltrating neutrophils to respond to IgG-containing immune complexes present in these joints.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227327      PMCID: PMC1363857          DOI: 10.1046/j.1365-2567.1997.00249.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  49 in total

1.  The Fc gamma receptor of natural killer cells is a phospholipid-linked membrane protein.

Authors:  D Simmons; B Seed
Journal:  Nature       Date:  1988-06-09       Impact factor: 49.962

2.  The PI-linked receptor FcRIII is released on stimulation of neutrophils.

Authors:  T W Huizinga; C E van der Schoot; C Jost; R Klaassen; M Kleijer; A E von dem Borne; D Roos; P A Tetteroo
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

3.  Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids.

Authors:  K C Petroni; L Shen; P M Guyre
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

4.  The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria.

Authors:  P Selvaraj; W F Rosse; R Silber; T A Springer
Journal:  Nature       Date:  1988-06-09       Impact factor: 49.962

5.  Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.

Authors:  J S Savill; A H Wyllie; J E Henson; M J Walport; P M Henson; C Haslett
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

6.  Oxygen-dependent killing of Staphylococcus aureus by human neutrophils.

Authors:  S W Edwards; J E Say; C A Hart
Journal:  J Gen Microbiol       Date:  1987-12

7.  Direct activation of neutrophil chemiluminescence by rheumatoid sera and synovial fluid.

Authors:  R Gale; J V Bertouch; J Bradley; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

8.  Multiple cytokine activities and loss of interleukin 2 inhibitor in synovial fluids of patients with rheumatoid arthritis.

Authors:  N Yamagata; K Kobayashi; T Kasama; T Fukushima; M Tabata; I Yoneya; Y Shikama; S Kaga; M Hashimoto; K Yoshida
Journal:  J Rheumatol       Date:  1988-11       Impact factor: 4.666

9.  Protein synthesis is activated in primed neutrophils: a possible role in inflammation.

Authors:  V Hughes; J M Humphreys; S W Edwards
Journal:  Biosci Rep       Date:  1987-11       Impact factor: 3.840

10.  Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.

Authors:  S J Hopkins; A Meager
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

View more
  19 in total

1.  Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS).

Authors:  S S Qureshi; S M Lewis; V A Gant; D Treacher; B H Davis; K A Brown
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

2.  Expression of CD11c and EMR2 on neutrophils: potential diagnostic biomarkers for sepsis and systemic inflammation.

Authors:  S M Lewis; D F Treacher; J Edgeworth; G Mahalingam; C S Brown; T A Mare; M Stacey; R Beale; K A Brown
Journal:  Clin Exp Immunol       Date:  2015-09-22       Impact factor: 4.330

3.  Neutrophil CD64 expression: distinguishing acute inflammatory autoimmune disease from systemic infections.

Authors:  E Allen; A C Bakke; M Z Purtzer; A Deodhar
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

4.  Major histocompatibility complex class II (DR) antigen and costimulatory molecules on in vitro and in vivo activated human polymorphonuclear neutrophils.

Authors:  Gavin P Sandilands; Jame McCrae; Kathryn Hill; Martin Perry; Derek Baxter
Journal:  Immunology       Date:  2006-10-11       Impact factor: 7.397

5.  Insoluble and soluble immune complexes activate neutrophils by distinct activation mechanisms: changes in functional responses induced by priming with cytokines.

Authors:  G Fossati; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  2002-01       Impact factor: 19.103

Review 6.  Diagnosing sepsis - The role of laboratory medicine.

Authors:  Shu-Ling Fan; Nancy S Miller; John Lee; Daniel G Remick
Journal:  Clin Chim Acta       Date:  2016-07-04       Impact factor: 3.786

7.  Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint.

Authors:  Ricardo Grieshaber-Bouyer; Tarik Exner; Nicolaj S Hackert; Felix A Radtke; Scott A Jelinsky; Olha Halyabar; Alexandra Wactor; Elham Karimizadeh; Joseph Brennan; Jorge Schettini; Helena Jonsson; Deepak A Rao; Lauren A Henderson; Carsten Müller-Tidow; Hanns-Martin Lorenz; Guido Wabnitz; James A Lederer; Angela Hadjipanayis; Peter A Nigrovic
Journal:  Ann Rheum Dis       Date:  2022-02-15       Impact factor: 27.973

Review 8.  The multifactorial role of neutrophils in rheumatoid arthritis.

Authors:  Helen L Wright; Robert J Moots; Steven W Edwards
Journal:  Nat Rev Rheumatol       Date:  2014-06-10       Impact factor: 20.543

9.  Febrile ulceronecrotic Mucha-Habermann disease following suspected hemorrhagic chickenpox infection in a 20-month-old boy.

Authors:  H N Lode; P Döring; P Lauenstein; P Hoeger; F Dombrowski; R Bruns
Journal:  Infection       Date:  2015-01-28       Impact factor: 7.455

Review 10.  Fcγ and Complement Receptors and Complement Proteins in Neutrophil Activation in Rheumatoid Arthritis: Contribution to Pathogenesis and Progression and Modulation by Natural Products.

Authors:  Adriana Balbina Paoliello-Paschoalato; Larissa Fávaro Marchi; Micássio Fernandes de Andrade; Luciana Mariko Kabeya; Eduardo Antônio Donadi; Yara Maria Lucisano-Valim
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.